Expert Consensus for Image-Guided Radiofrequency Ablation of Pulmonary Tumors_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

劉寶東 ,  支修益

首都醫科大學宣武醫院胸外科（北京 100053）;

Corresponding?author：

支修益, Email: xiuyizhi@aliyun.com

Keywords：

影像引導; 射頻消融; 肺部腫瘤; 專家共識

DOI：

10.7507/1007-4848.20150159

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

肺癌是最常見的惡性腫瘤之一，我國每年大約有60萬人死于肺癌，因此愈發引起關注。由中華醫學會胸心血管外科學會肺癌學組組織，首都醫科大學宣武醫院胸外科劉寶東起草，支修益組織國內相關專家在2014年10月至2014年11月通過討論、電子郵件等形式，反復征求參審專家的意見，達成了影像引導射頻消融治療肺部腫瘤的專家共識現已公布，旨在規范操作技術、進行療效評估、減少并發癥和提高治療效果。

Citation： 劉寶東, 支修益. Expert Consensus for Image-Guided Radiofrequency Ablation of Pulmonary Tumors. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2015, 22(7): 621-628. doi: 10.7507/1007-4848.20150159 Copy

1.	Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide:Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136(5):E359-E386.
2.	陳萬青, 張思維, 鄒小農, 等. 2004-2005年中國肺癌死亡情況分析. 中華預防醫學雜志, 2010, 44(5):378-382.
3.	She J, Yang P, Hong Q, et al. Lung cancer in China:challenge and inteventions. Chest, 2013, 143(4):1117-1126.
4.	Rose SC, Dupuy DE, Gervais DA, et al. Research reporting standards for percutaneous thermal ablation of lung neoplasms. J Vasc Interv Radiol, 2009, 20(7suppl):474-485.
5.	Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung AJR Am J Roentgenol, 2000, 174(1):57-59.
6.	Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer:results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg, 2007, 134(5):1306-1312.
7.	Hiraki T, GobaraH, Mimura H, et al. Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. J Thorac Cardiovasc Surg, 2011, 142(1):24-30.
8.	Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation:long-term safety and efficacy in 153 patients. Radiology, 2007, 243(1):268-275.
9.	Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg, 2008, 137(1):160-166.
10.	Pennathur A, Abbas G, Gooding WE, et al. Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service. Ann ThoracSurg, 2009, 88(5):1601-1608.
11.	Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours:a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol, 2008, 9(7):621-628.
12.	Ambrogi MC, Fanucchi O, Cioni R, et al. Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer:a prospective intention-to-treat study. J Thorac Oncol, 2011, 6(12):2044-2051.
13.	劉寶東, 劉磊, 李巖, 等. 射頻消融治療100例肺部腫瘤的遠期療效. 中國肺癌雜志, 2011, 14(4):335-339.
14.	Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy:a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol, 2000, 174(2):323-331.
15.	Hiraki T, Gobara H, Mimura H, et al. Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. J Thorac cardiovasc surg, 2011, 142(1):24-30.
16.	Beland MD, Wasser EJ, Mayo-Smith WW, et al. Primary non-small cell lung cancer:review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology, 2010, 254(1):301-307.
17.	Lanuti M, Sharma A, Willers H, et al. Radiofrequency ablation for stage I non-small cell lung cancer:management of locoregional recurrence. Ann Thorac Surg, 2012, 93(3):921-927.
18.	Li XQ, Zhang Y, Huang DB, et al. Value of C-arm computed tomography in radiofrequency ablation of small lung lesions. Genet Mol Res, 2014, 13(3):6027-6036.
19.	Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation:standardization of terminology and reporting criteria. Radiology, 2005, 235(3):728-739.
20.	Zhu JC, Yan TD, Morris DL. A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol, 2008, 15(6):1765-1774.
21.	Kashima M, Yamakado K, Takaki H, et al. Complications after 1,000 lung radiofrequency ablation sessions in 420 patients:a single center's experiences. AJR Am J Roentgenol, 2011, 197(40):W576-W580.
22.	Okuma T, Matsuoka T, Yamamoto A, et al. Frequency and risk factors of various complications after computed tomographyguided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol, 2008, 31(1):122-130.
23.	Hiraki T, Gobara H, Shibamoto K. et al. Technique for creationof artificial pneumothorax for pain relief during radiofrequency ablation of peripheral lung tumors:report of seven cases. J Vasc Interv Radiol, 2011, 22(4):503-506.
24.	Lee EW, Suh RD, Zeidler MR, et al. Ablation of subpleural lung malignancy:reduced pain using an artificially created pneumothorax. Cardiovasc Intervent Radiol, 2009, 32(4):833-836.
25.	Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors:incidence and risk factors. Radiology, 2006, 241(1):275-283.
26.	Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies:a large single-center experience. Cancer, 2007, 109(7):1397-1405.
27.	Abtin FG, Eradat J, Gutierrez AJ, et al. Radiofrequency ablation of lung tumors:imaging features of the postablationzone. Radiographics, 2012, 32(4):947-969.
28.	Palussière J, Marcet B, Descat E, et al. Lung tumors treated with percutaneous radiofrequency ablation:computed tomography imaging follow-up. Cardiovasc Intervent Radiol, 2011, 34(5):989-997.
29.	Gadaleta CD, Solbiati L, Mattioli V, et al. Unresectable lung malignancy:combination therapy with segmental pulmonary arterial chemoembolization with drug-eluting microspheres and radiofrequency ablation in 17 patients. Radiology, 2013, 267(2):627-637.
30.	Shen Y, Zhong M, Jiang W, et al. Video-assisted radiofrequency ablation for pleural disseminated non-small cell lung cancer. BMC Surg, 2013, 13(1):19.
31.	Dupuy DE, DiPetrillo T, Gandhi S, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest, 2006, 129(3):738-745.
32.	Li X, Zhao M, Wang J. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers. AJR Am J Roentgenol, 2013, 201(6):1362-1367.
33.	Weickhardt AJ, Scheier B, Burke JM, et al. Local ablative therapy of oligo progressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer. J Thorac Oncol, 2012, 7(2):1807-1814.
34.	Kim SR, Han HJ, Park SJ, et al. Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer. Eur J Radiol, 2012, 81(2):395-399.
35.	Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg, 2010, 211(1):68-72.
36.	Renaud S, Falcoz PE, Olland A, et al. Is radiofrequency ablation or stereotactic ablative radiotherapy the best treatment for radically treatable primary lung cancer unfit for surgery?. Interact Cardiovasc Thorac Surg, 2013, 16(1):68-73.
37.	Bilal H, Mahmood S, Rajashanker B, et al. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?. Interact Cardiovasc Thorac Surg, 2012, 15(2):258-265.

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide:Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136(5):E359-E386.
2. 陳萬青, 張思維, 鄒小農, 等. 2004-2005年中國肺癌死亡情況分析. 中華預防醫學雜志, 2010, 44(5):378-382.
3. She J, Yang P, Hong Q, et al. Lung cancer in China:challenge and inteventions. Chest, 2013, 143(4):1117-1126.
4. Rose SC, Dupuy DE, Gervais DA, et al. Research reporting standards for percutaneous thermal ablation of lung neoplasms. J Vasc Interv Radiol, 2009, 20(7suppl):474-485.
5. Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung AJR Am J Roentgenol, 2000, 174(1):57-59.
6. Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer:results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg, 2007, 134(5):1306-1312.
7. Hiraki T, GobaraH, Mimura H, et al. Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. J Thorac Cardiovasc Surg, 2011, 142(1):24-30.
8. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation:long-term safety and efficacy in 153 patients. Radiology, 2007, 243(1):268-275.
9. Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg, 2008, 137(1):160-166.
10. Pennathur A, Abbas G, Gooding WE, et al. Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service. Ann ThoracSurg, 2009, 88(5):1601-1608.
11. Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours:a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol, 2008, 9(7):621-628.
12. Ambrogi MC, Fanucchi O, Cioni R, et al. Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer:a prospective intention-to-treat study. J Thorac Oncol, 2011, 6(12):2044-2051.
13. 劉寶東, 劉磊, 李巖, 等. 射頻消融治療100例肺部腫瘤的遠期療效. 中國肺癌雜志, 2011, 14(4):335-339.
14. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy:a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol, 2000, 174(2):323-331.
15. Hiraki T, Gobara H, Mimura H, et al. Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. J Thorac cardiovasc surg, 2011, 142(1):24-30.
16. Beland MD, Wasser EJ, Mayo-Smith WW, et al. Primary non-small cell lung cancer:review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology, 2010, 254(1):301-307.
17. Lanuti M, Sharma A, Willers H, et al. Radiofrequency ablation for stage I non-small cell lung cancer:management of locoregional recurrence. Ann Thorac Surg, 2012, 93(3):921-927.
18. Li XQ, Zhang Y, Huang DB, et al. Value of C-arm computed tomography in radiofrequency ablation of small lung lesions. Genet Mol Res, 2014, 13(3):6027-6036.
19. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation:standardization of terminology and reporting criteria. Radiology, 2005, 235(3):728-739.
20. Zhu JC, Yan TD, Morris DL. A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol, 2008, 15(6):1765-1774.
21. Kashima M, Yamakado K, Takaki H, et al. Complications after 1,000 lung radiofrequency ablation sessions in 420 patients:a single center's experiences. AJR Am J Roentgenol, 2011, 197(40):W576-W580.
22. Okuma T, Matsuoka T, Yamamoto A, et al. Frequency and risk factors of various complications after computed tomographyguided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol, 2008, 31(1):122-130.
23. Hiraki T, Gobara H, Shibamoto K. et al. Technique for creationof artificial pneumothorax for pain relief during radiofrequency ablation of peripheral lung tumors:report of seven cases. J Vasc Interv Radiol, 2011, 22(4):503-506.
24. Lee EW, Suh RD, Zeidler MR, et al. Ablation of subpleural lung malignancy:reduced pain using an artificially created pneumothorax. Cardiovasc Intervent Radiol, 2009, 32(4):833-836.
25. Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors:incidence and risk factors. Radiology, 2006, 241(1):275-283.
26. Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies:a large single-center experience. Cancer, 2007, 109(7):1397-1405.
27. Abtin FG, Eradat J, Gutierrez AJ, et al. Radiofrequency ablation of lung tumors:imaging features of the postablationzone. Radiographics, 2012, 32(4):947-969.
28. Palussière J, Marcet B, Descat E, et al. Lung tumors treated with percutaneous radiofrequency ablation:computed tomography imaging follow-up. Cardiovasc Intervent Radiol, 2011, 34(5):989-997.
29. Gadaleta CD, Solbiati L, Mattioli V, et al. Unresectable lung malignancy:combination therapy with segmental pulmonary arterial chemoembolization with drug-eluting microspheres and radiofrequency ablation in 17 patients. Radiology, 2013, 267(2):627-637.
30. Shen Y, Zhong M, Jiang W, et al. Video-assisted radiofrequency ablation for pleural disseminated non-small cell lung cancer. BMC Surg, 2013, 13(1):19.
31. Dupuy DE, DiPetrillo T, Gandhi S, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest, 2006, 129(3):738-745.
32. Li X, Zhao M, Wang J. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers. AJR Am J Roentgenol, 2013, 201(6):1362-1367.
33. Weickhardt AJ, Scheier B, Burke JM, et al. Local ablative therapy of oligo progressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer. J Thorac Oncol, 2012, 7(2):1807-1814.
34. Kim SR, Han HJ, Park SJ, et al. Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer. Eur J Radiol, 2012, 81(2):395-399.
35. Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg, 2010, 211(1):68-72.
36. Renaud S, Falcoz PE, Olland A, et al. Is radiofrequency ablation or stereotactic ablative radiotherapy the best treatment for radically treatable primary lung cancer unfit for surgery?. Interact Cardiovasc Thorac Surg, 2013, 16(1):68-73.
37. Bilal H, Mahmood S, Rajashanker B, et al. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?. Interact Cardiovasc Thorac Surg, 2012, 15(2):258-265.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Expert Consensus for Image-Guided Radiofrequency Ablation of Pulmonary Tumors

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content